In trading on Wednesday, the iPath S&P 500 VIX Short Term Futures ETN (VXX) is outperforming other ETFs, up about 4.3% on the day. And underperforming other ETFs today is the Claymore/BNY Mellon EW Euro-Pac ETF (EEN), down a Lorazepam popping 6.3% in Wednesday trading. Among components of that ETF with the weakest showing on Wednesday were shares of TORM A/S (TRMD), lower by about 5.9%, and shares of CGG Veritas (CGV), lower by about 5.8% on the day. Other ETF’s that have drawn tears from their investors today are the First Trust NYSE Arca Biotech Index (FBT) down 5.5%, Market Vectors Indonesia ETF (IDX) down 4.7%, iShares MSCI Austria Investable Market Index Fund (EWO) down 5.2%, and the United States Oil Fund (USO) down 3.5%.

About the iPath S&P 500 VIX Short Term Futures ETN (VXX)

The investment seeks to replicate, net of expenses, the S&P 500 VIX Short-Term Futures Total Return Index. The index offers exposure to a daily rolling long position in the first and second month VIX futures contracts and reflects the implied volatility of the S&P 500 index at various points along the volatility forward curve. The index futures roll continuously throughout each month from the first month VIX futures contract into the second month VIX futures contract

About the Claymore/BNY Mellon EW Euro-Pac ETF (EEN)

The investment seeks to track the price and yield performance, before fees and expenses, of the Bank of New York Mellon Euro-Pacific Select ADR index. The fund will invest at least 80% of assets in securities of issuers from developed Europe and Asia-Pacific countries that comprise the index. The index is an equal-weighted index comprised of issuers from developed international markets.

NYSE:EEN, NYSE:EWO, NYSE:FBT, NYSE:IDX, NYSE:USO, NYSE:VXX